CONNECT WITH US
HealthTech

HealthTech

HealthSpan Partners ups Surgery Partners offer to $6B after rival bid

Healthcare Dive logo

Published on

Add as a preferred source on Google
HealthSpan Partners ups Surgery Partners offer to $6B after rival bid

An unsolicited bid from another company prompted the Bon Secours affiliate to offer $300 million more for the surgical facility network, giving shareholders even more if the deal takes longer.

Bon Secours Mercy Health’s affiliate HealthSpan Partners has sweetened its deal to buy Surgery Partners after the outpatient facility chain received a competing offer.

Under the new terms announced Monday, Surgery Partners’ shareholders would receive $25.00 per share in cash – up from $23.50 in the original agreement last month – in a deal worth $6 billion.

Although the deal is expected to close in the first quarter of next year, shareholders – excluding those linked to Surgery Partners' largest stakeholder Bain Capital Private Equity – would receive extra monthly payments if the close date is delayed after March 1, and could get up to $26.61 per share if the deal isn’t complete by Oct. 23.

Surgery Partners, which operates over 200 short-stay surgical facilities in 30 states, said the offer from an undisclosed bidder would have acquired the company for $28.00 per share, but that the deal would have taken “materially longer to close” compared to an acquisition by HealthSpan. It also risked being held up by regulators, the company said.

Bloomberg reported that UnitedHealth was the unidentified bidder. Surgery Partners did not respond to a request for comment on the bidder’s identity.

UnitedHealth has heavily invested in ASCs and other outpatient locations through its Optum subsidiary, which is one of the largest outpatient surgery operators in the country following its 2017 acquisition of SCA Health .


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.